Difference between revisions of "Bertran Auvert"

From IntactiWiki
Jump to navigation Jump to search
m (adjusted REFjournal)
m (using template BoyleGJ HillG 2011)
Line 134: Line 134:
 
}}</ref> Later in the interview he says "We also have 2 ongoing trials in Uganda and Kenya." (Notice the word "We" here.)
 
}}</ref> Later in the interview he says "We also have 2 ongoing trials in Uganda and Kenya." (Notice the word "We" here.)
  
Boyle & Hill (2011) have shown these coordinated RCTs to be have significant methodological flaws and statistical errors that render their claims invalid. Although a 60 percent ''relative'' reduction in HIV was claimed, the ''absolute'' reduction was a statistically insignificant 1.3 percent.<ref name="boyle-hill2011">{{REFjournal
+
Boyle & Hill (2011) have shown these coordinated RCTs to be have significant methodological flaws and statistical errors that render their claims invalid. Although a 60 percent ''relative'' reduction in HIV was claimed, the ''absolute'' reduction was a statistically insignificant 1.3 percent.<ref name="boyle-hill2011">{{BoyleGJ HillG 2011}}</ref>
|last=Boyle
 
|first=Gregory J.
 
|init=GJ
 
|author-link=
 
|last2=Hill
 
|first2=George
 
|init2=G
 
|author2-link=George Hill
 
|title=Sub-Saharan African randomised clinical trials into male circumcision and HIV transmission: Methodological, ethical and legal concerns
 
|journal=J Law Med
 
|date=2011-12
 
|volume=19
 
|issue=2
 
|pages=316-334
 
|url=http://www.salem-news.com/fms/pdf/2011-12_JLM-Boyle-Hill.pdf
 
|quote=
 
|pubmedID=22320006
 
|pubmedCID=
 
|DOI=
 
|accessdate=2020-04-10
 
}}</ref>
 
  
 
{{PUB}}
 
{{PUB}}

Revision as of 14:55, 30 December 2020

Example alt text
Bertran Auvert
Associates with:
Gilgal Society
Member of:
Bill & Melinda Gates Foundation
Colleagues & Benefactors:
Ronald H. Gray
Stephen Moses
Robert C. Bailey
Brian J. Morris
Bill Gates
Bill gates visit.jpg
Bill Gates, Bertran Auvert,
Dirk Taljaard, Cynthia Nhlapo

Bertran Auvert is a biased pro-circumcision researcher of French origin who has been a circumcision proponent since at least 2003.[1] Auvert was responsible for one of the three latest African circumcision trials,[2] which are being used by the World Health Organization to endorse circumcision as an HIV prevention method.[3] He associates with the Gilgal Society,[4] and is good friends with Bill Gates.[5]

Auvert's Circumcision Study

An RCT funded by the United States National Institutes of Health (NIH)[6] was carried out in Orange Farm, South Africa under the supervision of Bertran Auvert.[2] The British medical journal The Lancet decided against publishing Bertran's study. Lancet officials, following standard policy at the journal, refused to comment on why the study was turned down.[7]

In a Medscape interview, Bertran was asked, "in the group of men who were circumcised, I understand from the presentation that they were advised not to engage in sexual relations for approximately 5 weeks in order to recovery from the surgery. Is that correct?" Bertran replied, "Yes. We were very careful to recommend them to abstain from sex for 44 days, which is about 6 weeks after the surgical procedure, in order that they didn't have any risk of getting infected by HIV during this healing period."[8] Later in the interview he says "We also have 2 ongoing trials in Uganda and Kenya." (Notice the word "We" here.)

Boyle & Hill (2011) have shown these coordinated RCTs to be have significant methodological flaws and statistical errors that render their claims invalid. Although a 60 percent relative reduction in HIV was claimed, the absolute reduction was a statistically insignificant 1.3 percent.[9]

Publications

Bill Gates

Bertran Auvert, is so modest about his work, but he has new theories that we're putting money behind and he is just making it work.
– Bill Gates: Discussing Bertran's Circumcision "Studies" (Newsweek)[5]

See also

External links

References

  1. REFjournal Rain-Taljaard RC, Lagarde E, Taljaard DJ, Campbell C, MacPhail C, Williams B, Auvert B. Potential for an intervention based on male circumcision in a South African town with high levels of HIV infection. Aids Care. 15(3): 315-327.
  2. a b REFjournal Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A. Randomized, Controlled Intervention Trial of Male Circumcision for Reduction of HIV Infection Risk: The ANRS 1265 Trial. PLoS Med. 25 October 2005; 2(November 2005): e298. Retrieved 3 March 2011.
  3. REFweb World Health Oranization. WHO Male circumcision for HIV prevention. Retrieved 3 March 2011.
  4. REFweb Morris, Brian (2007). Sex and Circumcision What every Woman needs to know Icons-mini-file pdf.svg, The Gilgal Society. Retrieved 27 February 2011.
  5. a b REFweb Lyons, Daniel (25 January 2010). Saving The World, 2.0, Newsweek, Harman Newsweek LLC. Retrieved 3 March 2011.
  6. REFnews (2008)."The Use of Male Circumcision to Prevent HIV Infection", Doctors Opposing Circumcision. Retrieved 5 March 2011.
    Quote: ...funding from the United States National Institutes of Health to conduct randomized controlled trials (RCTs) in Africa.
  7. REFnews Schoofs, M. / S Lueck / M.M. Phillips (5 July 2005)."Study says circumcision reduces AIDS risk by 70%".
  8. REFweb Medscape (29 July 2005). Randomized Clinical Trial Shows Male Circumcision Has Great Potential to Curb HIV Infections in Africa, Medscape. Retrieved 3 March 2011.
  9. REFjournal Boyle GJ, Hill G. Sub-Saharan African randomised clinical trials into male circumcision and HIV transmission: Methodological, ethical and legal concerns PDF. Thompson Reuter. December 2011; 19(2): 316-34. PMID. Retrieved 30 December 2020.